Shandong Lu anti: net profit reduction loss growth of 66%
-
Last Update: 2020-07-01
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
August 31, 2013, Shandong Lu Anti-Pharmaceutical Co., Ltdpublished its 2013 semi-annual report, the company's first-half sales revenue of 117,324 million yuan, a decrease of 3.73% YoY;v5c
Among them, wholly-owned subsidiary Shandong Lu Anti-Bio Manufacturing Co., Ltd., main lyptopine manufacturing, sales; During the reporting period, operating income was RMB47.55 million and net profit was RMB21.45 millionv5cOn August 31, 2013, Shandong Lu Anti-Pharmaceutical Co., Ltdpublished its 2013 semi-annual report, the company's first-half sales revenue of 117,324 million yuan, a decrease of 3.73% YoY;v5c
Among them, wholly-owned subsidiary Shandong Lu Anti-Bio Manufacturing Co., Ltd., main lyptopine manufacturing, sales; During the reporting period, operating income was RMB47.55 million and net profit was RMB21.45 millionv5c
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
